Accelerate Diagnostics, Inc. (AXDX)Â
Trading
Quantity
Profitability
Ownership
Largest Insider Buys in Sector
AXDX Insider Trading Activity
AXDX Median Price and Trade Amounts History Chart
Statistics of Insider Transactions
Amount of Insider Buys and Sells
Buys | $314,000 | 1 | 9 |
Sells | $397,812 | 10 | 91 |
Related Transactions
| PATIENCE JOHN | director | 1 | $314,000 | 0 | $0 | $314,000 |
| Patience David | Chief Financial Officer | 0 | $0 | 2 | $12,151 | $-12,151 |
| Mertz Larry Michael | Chief Technology Officer | 0 | $0 | 3 | $13,344 | $-13,344 |
| Phillips Jack | Chief Executive Officer | 0 | $0 | 4 | $58,317 | $-58,317 |
| SCHULER JACK W | 0 | $0 | 1 | $314,000 | $-314,000 |
About Accelerate Diagnostics, Inc.
Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious or health care-associated infections, including gram-positive and gram-negative organisms. It also provides the Accelerate PhenoTest, a test kit for the system, which provides identify and antibiotic susceptibility testing results for patients suspected of bacteremia or fungemia, both life-threatening conditions with high morbidity and mortality risk. The company was formerly known as Accelr8 Technology Corporation and changed its name to Accelerate Diagnostics, Inc. in December 2012. Accelerate Diagnostics, Inc. was incorporated in 1982 and is headquartered in Tucson, Arizona.
Insider Activity of Accelerate Diagnostics, Inc.
Over the last 12 months, insiders at Accelerate Diagnostics, Inc. have bought $314,000 and sold $397,812 worth of Accelerate Diagnostics, Inc. stock.
On average, over the past 5 years, insiders at Accelerate Diagnostics, Inc. have bought $8.04M and sold $534,958 worth of stock each year.
Highest buying activity among insiders over the last 12 months: PATIENCE JOHN (director) — $314,000.
The last purchase of 200,000 shares for transaction amount of $314,000 was made by PATIENCE JOHN (director) on 2024‑12‑03.
List of Insider Buy and Sell Transactions, Accelerate Diagnostics, Inc.
| 2025-02-26 | Sale | Patience David | Chief Financial Officer | 535 0.0022% | $1.09 | $583 | -0.89% | |
| 2025-02-03 | Sale | Phillips Jack | Chief Executive Officer | 485 0.0019% | $1.35 | $655 | -13.64% | |
| 2024-12-03 | Sale | SCHULER JACK W | 200,000 0.7963% | $1.57 | $314,000 | -26.11% | ||
| 2024-12-03 | PATIENCE JOHN | director | 200,000 0.7963% | $1.57 | $314,000 | -26.11% | ||
| 2024-05-20 | Sale | Mertz Larry Michael | Chief Technology Officer | 361 0.0016% | $0.88 | $318 | +49.30% | |
| 2024-04-17 | Sale | Phillips Jack | Chief Executive Officer | 26,735 0.1307% | $0.78 | $20,853 | +72.44% | |
| 2024-04-12 | Sale | Phillips Jack | Chief Executive Officer | 26,545 0.1187% | $0.86 | $22,829 | +43.02% | |
| 2024-04-09 | Sale | Mertz Larry Michael | Chief Technology Officer | 13,984 0.0653% | $0.87 | $12,166 | +46.51% | |
| 2024-04-09 | Sale | Patience David | Chief Financial Officer | 13,296 0.0621% | $0.87 | $11,568 | +46.51% | |
| 2024-04-04 | Sale | Phillips Jack | Chief Executive Officer | 15,887 0.0821% | $0.88 | $13,981 | +50.02% | |
| 2024-04-04 | Sale | Mertz Larry Michael | Chief Technology Officer | 978 0.0051% | $0.88 | $861 | +50.02% | |
| 2024-02-26 | Sale | Patience David | Chief Financial Officer | 350 0.0016% | $0.96 | $336 | +30.21% | |
| 2024-02-01 | Sale | Phillips Jack | Chief Executive Officer | 494 0.0024% | $1.30 | $642 | -0.41% | |
| 2024-01-23 | PATIENCE JOHN | director | 16,666 0.1274% | $1.50 | $24,999 | -8.21% | ||
| 2024-01-23 | Strobeck Matthew | director | 100,000 0.7643% | $1.50 | $150,000 | -8.21% | ||
| 2024-01-23 | MASSARANY HANY | director | 16,666 0.1274% | $1.50 | $24,999 | -8.21% | ||
| 2024-01-23 | FRANCESCONI LOUISE | director | 13,333 0.1019% | $1.50 | $20,000 | -8.21% | ||
| 2023-12-13 | Sale | Phillips Jack | Chief Executive Officer | 739 0.0048% | $4.39 | $3,244 | -70.52% | |
| 2023-12-13 | Sale | Patience David | Chief Financial Officer | 97 0.0006% | $4.39 | $426 | -70.52% | |
| 2023-10-13 | Sale | Phillips Jack | Chief Executive Officer | 734 0.0051% | $5.83 | $4,279 | -77.72% |
Insider Historical Profitability
| SCHULER JACK W | 8310388 33.1834% | $8.81M | 125 | 1 | +5.48% | |
| PATIENCE JOHN | director | 653224 2.6083% | $692,417.44 | 12 | 0 | +20.87% |
| Phillips Jack | Chief Executive Officer | 163434 0.6526% | $173,240.04 | 0 | 25 | |
| Mertz Larry Michael | Chief Technology Officer | 81831 0.3268% | $86,740.86 | 2 | 5 | <0.0001% |
| Patience David | Chief Financial Officer | 51384 0.2052% | $54,467.04 | 0 | 11 | |
| ABEJA VENTURES, LLC | 10 percent owner | 14000000 55.9021% | $14.84M | 1 | 0 | |
| DDX INC /CO/ | 10 percent owner | 1106793 4.4194% | $1.17M | 0 | 5 | |
| ARNOLD A ALEXANDER III | director | 793000 3.1665% | $840,580.00 | 0 | 1 | |
| Mehren Lawrence | PRESIDENT AND CEO | 762381 3.0442% | $808,123.86 | 2 | 2 | <0.0001% |
| GEIMER THOMAS J | CEO/CFO | 454500 1.8148% | $481,770.00 | 8 | 0 | |
| REICHLING STEVEN | Chief Financial Officer | 142370 0.5685% | $150,912.20 | 5 | 12 | +16.6% |
| GERRETSON CHARLES E | director | 140150 0.5596% | $148,559.00 | 10 | 2 | |
| Strobeck Matthew | director | 120682 0.4819% | $127,922.92 | 8 | 0 | +22.31% |
| Price Ron | Head of Commercial Operations | 40610 0.1622% | $43,046.60 | 0 | 3 | |
| FEINBERG LARRY N | 10 percent owner | 33079 0.1321% | $35,063.74 | 27 | 1 | +45.53% |
| Kucera John D. | director | 28663 0.1145% | $30,382.78 | 4 | 0 | |
| MASSARANY HANY | director | 24260 0.0969% | $25,715.60 | 3 | 0 | <0.0001% |
| FRANCESCONI LOUISE | director | 20927 0.0836% | $22,182.62 | 1 | 0 | <0.0001% |
| Brown Thomas D | director | 20500 0.0819% | $21,730.00 | 2 | 0 | +28.05% |
| TEN BRINK FRANK JM | director | 9800 0.0391% | $10,388.00 | 1 | 0 | +7.38% |
| Howson David | President | 2600 0.0104% | $2,756.00 | 6 | 0 | |
| HUMPHRIES ROMNEY | Chief Scientific Officer | 0 0% | $0 | 0 | 3 |
AXDX Institutional Investors: Active Positions
| Increased Positions | 15 | +26.79% | 212,435 | +4.42% |
| Decreased Positions | 17 | -30.36% | 301,786 | -6.28% |
| New Positions | 8 | New | 101,916 | New |
| Sold Out Positions | 6 | Sold Out | 33,060 | Sold Out |
| Total Postitions | 54 | -3.57% | 5M | -1.86% |
AXDX Ownership Change vs Market
Institutional Investor Ownership
| Armistice Capital, Llc | $2,390.00 | 8.31% | 2.08M | -23,000 | -1.09% | 2024-12-31 |
| Griffin Asset Management, Inc. | $1,154.00 | 4.01% | 1M | -241,774 | -19.41% | 2024-12-31 |
| Vanguard Group Inc | $550.00 | 1.91% | 478,093 | +5,059 | +1.07% | 2024-12-31 |
| Birchview Capital, Lp | $374.00 | 1.3% | 325,239 | 0 | 0% | 2024-12-31 |
| Geode Capital Management, Llc | $156.00 | 0.54% | 135,732 | +8,777 | +6.91% | 2024-12-31 |
| Cannell & Spears Llc | $132.00 | 0.46% | 114,523 | 0 | 0% | 2024-12-31 |
| Renaissance Technologies Llc | $123.00 | 0.43% | 107,062 | +65,984 | +160.63% | 2024-12-31 |
| Tci Wealth Advisors, Inc. | $64.00 | 0.22% | 55,586 | 0 | 0% | 2024-12-31 |
| Blackrock, Inc. | $58.00 | 0.2% | 50,842 | 0 | 0% | 2024-12-31 |
| Cladis Investment Advisory, Llc | $49.00 | 0.17% | 42,700 | +3,000 | +7.56% | 2024-12-31 |